Across TCGA pan-cancer cohorts, OR9M1P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR9M1P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher OR9M1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR9M1P expression acts as an unfavorable survival marker.

UVM, LUSC, and PAAD are the cancer types where OR9M1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
LUSC	OS	Tertile	III,IV	0.011	0.684	<.001	72	view →
PAAD	OS	Tertile	All	0.221	0.620	<.001	72	view →
GBM	OS	Tertile	All	0.103	0.415	.003	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
KIRP	DFS	Tertile	III,IV	0.038	0.723	<.001	27	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
UCEC	OS	Tertile	All	0.786	0.928	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

Exploration

Same gene, other analysis: OR9M1P tumor-vs-normal RNA expression · all OR9M1P data types